Related to Cellectis Wins Up to $9.5M NIH Stem Cell Contract

• UC San Diego and Salk Institute to Conduct Cell Transplant Research for ALS with $11.5M
  
• NIH and Wellcome Trust Pledge $38M for Population-Based Genetic Studies in Africa
  
• CIRM Commits $25M to Overcome Immune Rejection of Stem Cell Therapies
  
• Diabetes Therapy Company Poxel Raises $21M in Series A Financing
  
• NIH to Fund 10 Malaria Research Centers with $14M in the First Year
  
• NIH Prolongs Compound-Management Arrangement with Galapagos Until End of 2012
  
• ISCO Partners with IBVI to Set Up Indian Facility for Stem Cell Therapies
  
• Cara Raises $15M in Series D Fundraising for Phase II Development of Pain Relief Drug
  
• Cerenis Raises €40M in Series C and Wins €10.7M from French Government
  
• Titan Wins up to $500K in SBIR Grants to Evaluate Six-Month Implant Therapy for Parkinson Disease
  
• Stem Cell Differentiation Linked to Scaffold’s Mechanical Forces
  
• NIH Bankrolls Six Centers with $100M to Characterize Human Immune Responses
  
• Selecta Awarded $3M by NIDA to Progress Synthetic Nicotine Vaccine into Clinic
  
• TRI Wins up to $75M Contract to Provide AIDS-Related CRO Services
  
• Scientists Direct Adult Stem Cells to Repair the Heart
  
• California Institute for Regenerative Medicine Bankrolls 12 Grants with $243M
  
• Surface that Enables Stem Cell Growth for up to Three Months Developed
  
• Court Temporarily Blocks Federal Funding of ESCs
  
• Liver Cells Created from Skin Cells
  
• Veritas to Market Epistem’s Epithelial Stem Cell-Based Research Services in Japan